GlassScriptPhysician profile
Kyle Jonathan Stansifer
NPI 1962766600
$3,441.50
in general payments reported to CMS, 2019-2025
10 companies · $2,082 in 2025
The $2,082 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $33.72 · 2021: $80.62 · 2022: $107 · 2023: $600 · 2024: $365 · 2025: $2,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,038 · Travel and Lodging: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,038.08 |
| Travel and Lodging | $1,007.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,604.87 | 2023-2025 | |
| Medtronic, INC. | $320.72 | 2022-2025 | Propel, Nuvent |
| Optinose US, INC. | $141.34 | 2020-2023 | |
| Intersect Ent, INC. | $140.62 | 2019 | |
| Stryker Corporation | $61.21 | 2019-2022 | |
| Neurent Medical Limited | $56.40 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Acclarent, INC | $51.11 | 2019-2024 | Acclarent Aera |
| Genzyme Corporation | $23.22 | 2021 | |
| Amgen INC. | $22.34 | 2025 | Tezspire |
| Smith+Nephew, INC. | $19.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Stansifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.